Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Viking Thera (VKTX)
Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,087,315
  • Shares Outstanding, K 100,029
  • Annual Sales, $ 0 K
  • Annual Income, $ -68,870 K
  • 60-Month Beta 0.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.91
Trade VKTX with:

Options Overview Details

View History
  • Implied Volatility 233.45% ( +48.47%)
  • Historical Volatility 58.10%
  • IV Percentile 99%
  • IV Rank 70.75%
  • IV High 310.17% on 10/24/22
  • IV Low 47.86% on 08/30/23
  • Put/Call Vol Ratio 0.91
  • Today's Volume 955
  • Volume Avg (30-Day) 3,672
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 76,311
  • Open Int (30-Day) 76,772

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.22
  • Number of Estimates 8
  • High Estimate -0.18
  • Low Estimate -0.24
  • Prior Year -0.21
  • Growth Rate Est. (year over year) -4.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.45 +2.68%
on 10/03/23
16.36 -34.41%
on 09/11/23
-3.78 (-26.05%)
since 09/01/23
3-Month
10.45 +2.68%
on 10/03/23
16.36 -34.41%
on 09/11/23
-4.71 (-30.51%)
since 07/03/23
52-Week
2.71 +295.94%
on 10/05/22
25.72 -58.28%
on 05/23/23
+8.01 (+294.49%)
since 10/03/22

Most Recent Stories

More News
$VKTX: Consolidation in Viking Therapeutics Provides an Opportunity

Viking Therapeutics Inc. (VKTX) is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases. Metabolic and rare disease programs include novel selective thyroid...

VKTX : 10.73 (-1.29%)
Viking Therapeutics to Participate at Upcoming Investor Conferences

/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...

VKTX : 10.73 (-1.29%)
Viking Therapeutics Announces Initiation of Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity

/PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

VKTX : 10.73 (-1.29%)
3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy?

NASH treatments are projected to be one of the most sought-after indications in the coming years.

MDGL : 140.83 (-1.76%)
TERN : 4.99 (+1.63%)
VKTX : 10.73 (-1.29%)
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It

NASH is a surprisingly common ailment, and the first treatments are on the way.

GILD : 73.22 (-1.19%)
NVO : 87.79 (-4.37%)
LLY : 525.08 (-2.45%)
TERN : 4.99 (+1.63%)
VKTX : 10.73 (-1.29%)
MDGL : 140.83 (-1.76%)
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today

Novo Nordisk's popular weight loss drug also confers a significant cardioprotective effect, according to a new study.

LLY : 525.08 (-2.45%)
NVO : 87.79 (-4.37%)
VKTX : 10.73 (-1.29%)
2 Magnificient Growth Stocks I'm Buying in August

These biotech stocks could markedly outperform the broader market.

ROIV : 10.40 (-1.14%)
VKTX : 10.73 (-1.29%)
Viking Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...

VKTX : 10.73 (-1.29%)
Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush

A bid to acquire Versanis boosts Eli Lilly & Co. by 2.80% in the past week, as the competition to develop the most effective weight-loss drug intensifies.

LLY : 525.08 (-2.45%)
AMGN : 260.84 (-2.05%)
NVS : 99.46 (-2.05%)
NVO : 87.79 (-4.37%)
VKTX : 10.73 (-1.29%)
3 Small-Cap Stocks That Could Be Big-Time Winners

These stocks come with significant risks. But they could generate huge returns over time.

BLUE : 3.01 (+2.38%)
TVTX : 8.55 (+1.54%)
VKTX : 10.73 (-1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 11.37
2nd Resistance Point 11.23
1st Resistance Point 11.05
Last Price 10.73
1st Support Level 10.72
2nd Support Level 10.58
3rd Support Level 10.40

See More

52-Week High 25.72
Fibonacci 61.8% 16.93
Fibonacci 50% 14.21
Fibonacci 38.2% 11.50
Last Price 10.73
52-Week Low 2.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar